Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_assertion type Assertion NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_head.
- NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_assertion description "[We established an ELISA to measure serum LY6K and found that the proportion of the serum LY6K-positive cases was 38 of 112 (33.9%) NSCLC and 26 of 81 (32.1%) ESCC, whereas only 3 of 74 (4.1%) healthy volunteers were falsely diagnosed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_provenance.
- NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_assertion evidence source_evidence_literature NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_provenance.
- NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_assertion SIO_000772 18089789 NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_provenance.
- NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_assertion wasDerivedFrom befree-20150227 NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_provenance.
- NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_assertion wasGeneratedBy ECO_0000203 NP913712.RA9V-1HP3FCIEkk3tgv5jCU-ZbZ5B9fa4nszAvy4NZx-8130_provenance.